Waters XBridge Premier GTx BEH SEC columns for gene therapy applications
Waters has introduced the first product in its line of size-exclusion chromatography (SEC) columns aimed at improving analysis while lowering the cost of gene therapies, specifically adeno-associated viral (AAV) vectors.
The Waters XBridge Premier GTx BEH SEC columns are designed to double the speed of measuring the potency and safety of AAVs. Combining the columns with light-scattering technologies from the company’s Wyatt Technology portfolio deepens the level of information acquired from a single experiment and optimises the manufacturing of these novel gene delivery vehicles — quadrupling sensitivity and increasing resolution of target analytes by up to 50%, the company says.
AAVs are modified viruses made in bioreactors by living cells and are a leading vehicle for carrying therapeutic genes into human cells. It is important that process and formulation development tests measure multiple attributes of the gene therapies at once while consuming as little of them as possible.
Waters’ low-adsorption, high-efficiency SEC columns are claimed to use 3–10x less sample than other methods, while generating faster results and more drug substance information. This makes them a good choice for process development, formulation studies and regulatory filing support, along with ongoing process monitoring and quality control.
Phone: 02 9933 1777
CoolLED pE-300white LED illumination system for fluorescence microscopy
The system delivers powerful, broad-spectrum LED illumination designed for fluorescence...
BUCHI ProxiMate and ProxiScout NIR systems
ProxiMate is an at-line NIR instrument specifically designed for the food and feed industry,...
LICORbio Atlas for 2D and 3D cell imaging
Designed for both 2D and 3D assays, the product delivers high-content, high-throughput imaging in...